These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22820248)

  • 1. Ursodeoxycholic acid stimulates the formation of the bile canalicular network.
    Ikebuchi Y; Shimizu H; Ito K; Yoshikado T; Yamanashi Y; Takada T; Suzuki H
    Biochem Pharmacol; 2012 Oct; 84(7):925-35. PubMed ID: 22820248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat.
    Rodríguez-Ortigosa CM; Banales JM; Olivas I; Uriarte I; Marín JJ; Corrales FJ; Medina JF; Prieto J
    Hepatology; 2010 Aug; 52(2):667-77. PubMed ID: 20683964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
    Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
    Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid choleresis: relationship to biliary HCO-3 and effects of Na+-H+ exchange inhibitors.
    Renner EL; Lake JR; Cragoe EJ; Van Dyke RW; Scharschmidt BF
    Am J Physiol; 1988 Feb; 254(2 Pt 1):G232-41. PubMed ID: 2831731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Na+ replacement and amiloride on ursodeoxycholic acid-stimulated choleresis and biliary bicarbonate secretion.
    Lake JR; Van Dyke RW; Scharschmidt BF
    Am J Physiol; 1987 Feb; 252(2 Pt 1):G163-9. PubMed ID: 3826345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid induced activation of the glucocorticoid receptor in primary rat hepatocytes.
    Weitzel C; Stark D; Kullmann F; Schölmerich J; Holstege A; Falk W
    Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):169-77. PubMed ID: 15674094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
    Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants.
    Mitsuyoshi H; Nakashima T; Sumida Y; Yoh T; Nakajima Y; Ishikawa H; Inaba K; Sakamoto Y; Okanoue T; Kashima K
    Biochem Biophys Res Commun; 1999 Sep; 263(2):537-42. PubMed ID: 10491327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
    Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
    J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway.
    Rajesh KG; Suzuki R; Maeda H; Yamamoto M; Yutong X; Sasaguri S
    J Mol Cell Cardiol; 2005 Nov; 39(5):766-76. PubMed ID: 16171810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical pharmacology of ursodeoxycholic acid (UDCA)].
    Kryczka W; Grieb P
    Postepy Hig Med Dosw; 1994; 48(1):53-68. PubMed ID: 8058580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress.
    Serviddio G; Pereda J; Pallardó FV; Carretero J; Borras C; Cutrin J; Vendemiale G; Poli G; Viña J; Sastre J
    Hepatology; 2004 Mar; 39(3):711-20. PubMed ID: 14999689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
    Choi SW; Han JH; Lim KT; Cho HM; Chung KW; Sun HS; Park DH; Kim BS; Seo EJ
    J Korean Med Sci; 1991 Jun; 6(2):146-56. PubMed ID: 1751019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat.
    Úriz M; Sáez E; Prieto J; Medina JF; Banales JM
    PLoS One; 2011; 6(12):e28717. PubMed ID: 22194894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver.
    Beuers U; Bilzer M; Chittattu A; Kullak-Ublick GA; Keppler D; Paumgartner G; Dombrowski F
    Hepatology; 2001 May; 33(5):1206-16. PubMed ID: 11343250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury.
    Pathil A; Warth A; Chamulitrat W; Stremmel W
    J Hepatol; 2011 Apr; 54(4):674-84. PubMed ID: 21146893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid enhances glucocorticoid-induced tyrosine aminotransferase-gene expression in cultured rat hepatocytes.
    Mitsuyoshi H; Nakashima T; Inaba K; Ishikawa H; Nakajima Y; Sakamoto Y; Matsumoto M; Okanoue T; Kashima K
    Biochem Biophys Res Commun; 1997 Nov; 240(3):732-6. PubMed ID: 9398635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
    Nowak G; Norén UG; Wernerson A; Marschall HU; Möller L; Ericzon BG
    Transpl Int; 2005 May; 17(12):804-9. PubMed ID: 15815896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways.
    Schoemaker MH; Conde de la Rosa L; Buist-Homan M; Vrenken TE; Havinga R; Poelstra K; Haisma HJ; Jansen PL; Moshage H
    Hepatology; 2004 Jun; 39(6):1563-73. PubMed ID: 15185297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.